The American Journal of Medicine
Volume 121, Issue 6 , Pages 509-514 , June 2008

Sex Differences in Ambulatory Blood Pressure Monitoring

  • Iddo Z. Ben-Dov, MD, MSc

      Affiliations

    • Nephrology and Hypertension Services, Hadassah – Hebrew University Medical Center, Jerusalem, Israel
    • Corresponding Author InformationRequests for reprints should be addressed to Iddo Ben-Dov, MD, MSc, Nephrology and Hypertension Services, Hadassah – Hebrew University Medical Center, Ein-Kerem, PO Box 12000, Jerusalem, Israel 91120.
  • ,
  • Judith Mekler, MSc

      Affiliations

    • Department of Internal Medicine, Mount Scopus Campus, Hadassah – Hebrew University Medical Center, Jerusalem, Israel.
  • ,
  • Michael Bursztyn, MD

      Affiliations

    • Department of Internal Medicine, Mount Scopus Campus, Hadassah – Hebrew University Medical Center, Jerusalem, Israel.

References 

  1. Douglas PS, Ginsburg GS. The evaluation of chest pain in women. N Engl J Med. 1996;334(20):1311–1315
  2. Cornoni-Huntley J, LaCroix AZ, Havlik RJ. Race and sex differentials in the impact of hypertension in the United States (The National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study). Arch Intern Med. 1989;149(4):780–788
  3. Sullivan AK, Holdright DR, Wright CA, et al. Chest pain in women: clinical, investigative, and prognostic features. BMJ. 1994;308(6933):883–886
  4. Pickering TG, Shimbo D, Haas D. Ambulatory Blood-Pressure Monitoring. N Engl J Med. 2006;354(22):2368–2374
  5. O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet. 1988;2(8607):397
  6. Verdecchia P, Schillaci G, Borgioni C, et al. Adverse prognostic value of a blunted circadian rhythm of heart rate in essential hypertension. J Hypertens. 1998;16(9):1335–1343
  7. Ben Dov IZ, Kark JD, Ben Ishay D, et al. Blunted heart rate dip during sleep and all-cause mortality. Arch Intern Med. 2007;167(19):2116–2121
  8. Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348(24):2407–2415
  9. Imai Y, Ohkubo T, Sakuma M, et al. Predictive power of screening blood pressure, ambulatory blood pressure and blood pressure measured at home for overall and cardiovascular mortality: a prospective observation in a cohort from Ohasama, northern Japan. Blood Press Monit. 1996;1(3):251–254
  10. Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111(14):1777–1783
  11. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension (Systolic Hypertension in Europe Trial Investigators). JAMA. 1999;282(6):539–546
  12. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure (An independent predictor of prognosis in essential hypertension). [published erratum appears in Hypertension 1995 Mar;25(3):462] Hypertension. 1994;24(6):793–801
  13. Ohkubo T, Imai Y, Tsuji I, et al. Reference values for 24-hour ambulatory blood pressure monitoring based on a prognostic criterion: the Ohasama study. Hypertension. 1998;32(2):255–259
  14. Falconnet C, Bochud M, Bovet P, et al. Gender difference in the response to an angiotensin-converting enzyme inhibitor and a diuretic in hypertensive patients of African descent. J Hypertens. 2004;22(6):1213–1220
  15. Asmar R, Brisac AM, Courivaud JM, et al. Influence of gender on the level of pulse pressure: the role of large conduit arteries. Clin Exp Hypertens. 1997;19(5-6):793–811
  16. Kagan A, Faibel H, Ben Arie G, et al. Gender differences in ambulatory blood pressure monitoring profile in obese, overweight and normal subjects. J Hum Hypertens. 2007;21(2):128–134
  17. Goldstein IB, Shapiro D, Guthrie D. Ambulatory blood pressure and family history of hypertension in healthy men and women. Am J Hypertens. 2006;19(5):486–491
  18. Kario K, Schwartz JE, Davidson KW, Pickering TG. Gender differences in associations of diurnal blood pressure variation, awake physical activity, and sleep quality with negative affect: the work site blood pressure study. Hypertension. 2001;38(5):997–1002
  19. Zemva A, Rogel P. Gender differences in athlete's heart: association with 24-h blood pressure (A study of pairs in sport dancing). Int J Cardiol. 2001;77(1):49–54
  20. Jaquet F, Goldstein IB, Shapiro D. Effects of age and gender on ambulatory blood pressure and heart rate. J Hum Hypertens. 1998;12(4):253–257
  21. Vriz O, Lu H, Visentin P, et al. Gender differences in the relationship between left ventricular size and ambulatory blood pressure in borderline hypertension (The HARVEST Study). Eur Heart J. 1997;18(4):664–670
  22. Steingart RM, Packer M, Hamm P, et al. Sex differences in the management of coronary artery disease (Survival and Ventricular Enlargement Investigators). N Engl J Med. 1991;325(4):226–230
  23. Shaw LJ, Miller DD, Romeis JC, et al. Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease. Ann Intern Med. 1994;120(7):559–566
  24. Grin JM, McCabe EJ, White WB. Management of hypertension after ambulatory blood pressure monitoring. Ann Intern Med. 1993;118(11):833–837
  25. Groppelli A, Omboni S, Parati G, Mancia G. Evaluation of noninvasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24-hour intra-arterial blood pressure. Hypertension. 1992;20(2):227–232
  26. Ben Dov IZ, Kark JD, Ben Ishay D, et al. Predictors of all-cause mortality in clinical ambulatory monitoring: unique aspects of blood pressure during sleep. Hypertension. 2007;49(6):1235–1241
  27. Perk G, Mekler J, Bursztyn M. Ambulatory pulse pressure is a relatively sleep-independent variable. J Hypertens. 2003;21(4):723–728
  28. Owens P, Atkins N, O'Brien E. Diagnosis of white coat hypertension by ambulatory blood pressure monitoring. Hypertension. 1999;34(2):267–272
  29. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111(5):697–716
  30. O'Brien E, Asmar R, Beilin L, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens. 2003;21(5):821–848
  31. Ben Dov IZ, Kark JD, Mekler J, et al. The white coat phenomenon is benign in referred treated patients: a 14-year ambulatory blood pressure mortality study. J Hypertens. 2008;26:699–705
  32. Pilote L, Hlatky MA. Attitudes of women toward hormone therapy and prevention of heart disease. Am Heart J. 1995;129(6):1237–1238
  33. Spruill TM, Pickering TG, Schwartz JE, et al. The impact of perceived hypertension status on anxiety and the white coat effect. Ann Behav Med. 2007;34(1):1–9
  34. Myers MG, Reeves RA. White coat effect in treated hypertensive patients: sex differences. J Hum Hypertens. 1995;9(9):729–733
  35. Martinez MA, Garcia-Puig J, Martin JC, et al. Frequency and determinants of white coat hypertension in mild to moderate hypertension: a primary care-based study (Monitorizacion Ambulatoria de la Presion Arterial (MAPA)-Area 5 Working Group). Am J Hypertens. 1999;12(3):251–259
  36. Dolan E, Stanton A, Atkins N, et al. Determinants of white-coat hypertension. Blood Press Monit. 2004;9(6):307–309
  37. Den Hond E, Celis H, Vandenhoven G, et al. Determinants of white-coat syndrome assessed by ambulatory blood pressure or self-measured home blood pressure. Blood Press Monit. 2003;8(1):37–40
  38. MacDonald MB, Laing GP, Wilson MP, Wilson TW. Prevalence and predictors of white-coat response in patients with treated hypertension. CMAJ. 1999;161(3):265–269
  39. Neumann SA, Jennings JR, Muldoon MF, Manuck SB. White-coat hypertension and autonomic nervous system dysregulation. Am J Hypertens. 2005;18(5 Pt 1):584–588
  40. Fagard RH, Stolarz K, Kuznetsova T, et al. Sympathetic activity, assessed by power spectral analysis of heart rate variability, in white-coat, masked and sustained hypertension versus true normotension. J Hypertens. 2007;25(11):2280–2285
  41. Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25(11):2193–2198
  42. Ferrara A, Mangione CM, Kim C, et al. Gender disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care. 2008;31:69–74
  43. Chou AF, Wong L, Weisman CS, et al. Gender disparities in cardiovascular disease care among commercial and medicare managed care plans. Womens Health Issues. 2007;17(3):139–149
  44. Fang J, Alderman MH. Gender differences of revascularization in patients with acute myocardial infarction. Am J Cardiol. 2006;97(12):1722–1726

 This study was supported in part by a research prize from the Israel Society of Hypertension.

PII: S0002-9343(08)00191-5

doi: 10.1016/j.amjmed.2008.02.019

The American Journal of Medicine
Volume 121, Issue 6 , Pages 509-514 , June 2008